Control of lipid storage and cell size between adipocytes by vesicle-associated glycosylphosphatidylinositol-anchored proteins

Archives of Physiology and Biochemistry

Volumn 117, Issue 1, 2011, Pages 23-43

  Müller, Günter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adiposomes; Exosomes; Glycosylphosphatidylinositol; Lipid droplets; Lipid metabolism; Lipid rafts; Micro vesicles; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL; HYDROLASE; INSULIN; LIPID LINKED PROTEIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CELL MEMBRANE; CELL POLARITY; CELL SIZE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; LIPID METABOLISM; LIPOLYSIS; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; TRANSPORT VESICLE; ULTRASTRUCTURE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; CELL POLARITY; CELL SIZE; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; HYDROLASES; HYPOGLYCEMIC AGENTS; INSULIN; LIPID METABOLISM; LIPID-LINKED PROTEINS; LIPOLYSIS; MEMBRANE MICRODOMAINS; MICE; RATS; TRANSPORT VESICLES; TRIGLYCERIDES;

ANIMALIA; MAMMALIA; RATTUS;

EID: 78651238421     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2010.513393     Document Type: Review

References (141)

1. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD. (2004). Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53:585-90. (Pubitemid 38270626)
2. Ahmadian M, Duncan RE, Sul HS. (2009). The skinny on fat: lipolysis and fatty acid utilization in adipocytes. Trends Endocrinol Metab 20:424-8.
3. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. (2009). Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:3794-9.
4. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Cell Biol 10:619-24.
5. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, Tamura N, Tamura T, Matsuda T. (2007). Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule- epidermal growth factor 8-associated microvesicles. Endocrinology 148:3850-62.
6. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. (1990). Biological properties of recombinant human monocytederived interleukin 1 receptor antagonist. J Clin Invest 85:1694-7.
7. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83.
8. Azain MJ. (2004). Role of FA in adipocyte growth and development. J Anim Sci 82:916-24.
9. Azain MJ, Hausman DB, Sisk MB, Flatt WP, Jewell DE. (2000). Dietary conjugated linoleic acid reduces rat adipose tissue cell size. J Nutr 130:1548-54.
10. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. (2006). Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55:2277-85.
11. Björntorp P, Karlsson M. (1970). Triglyceride synthesis in human subcutaneous adipose tissue cells of different size. Eur J Clin Invest 1:112-7.
12. Björntorp P. (1974). Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 23:1091-102.
13. Björntorp P, Carlgren G, Isaksson B, Krotkiewski M, Larsson B, Sjöström L. (1975). Effect of an energy reduced dietry regimen in relation to adipose tissue cellularity in obese women. Am J Clin Nut 28:445-52.
14. Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR. (2002). Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25-38.
15. Blüher M, Patti ME, Gesta S, Kahn BB, Kahn CR. (2004). Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J Biol Chem 279:31891-901.
16. Bradley RL, Cleveland KA, Cheatham B. (2001). The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. Recent Prog Horm Res 56:329-58.
17. Cartwright MJ, Tchkonia T, Kirkland JL. (2007). Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms. Exper Gerontol 42:463-71.
18. Chavez JA, Summers SA. (2010). Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms. Biochim Biophys Acta 1801:252-65.
19. Coleman RA, Lewin TM, Muoio DM. (2000). Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu Rev Nutr 20:77-103.
20. Danforth E. (2000). Failure of adipocyte differentiation causes type II diabetes mellitus ? Nat Genet 26:13.
21. DeFronzo RA. (2004). Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 143:9-21.
22. del Conde, Shrimpton CN, Thiagarajan P, Lopez JA. (2005). Tissuefactor- bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604-11.
23. Despres JP, Fong BS, Julien P, Jimenez J, Angel A. (1987). Regional variation in HDL metabolism in human fat cells: effect of cell size. Am J Physiol 252:E654-9.
24. Despres JP, Lamarche B, Maurige P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. (1996). Hyperinsulinemia as an independent risk factor for ischemic heart disease. The New Engl J Med 334:952-7. (Pubitemid 26114161)
25. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV. (2003). RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptotsis of LNCaP prostate cancer cells. Cancer Res 63:3799-904.
26. Egan JJ, Greenberg AS, Chang M-K, Wek SA, Moos MC, Londos C. (1992). Mechanism of hormone-stimulated lipolysis in adipocytes: Translocation of hormone-sensitive lipase to the lipid storage droplet. Proc Natl Acad Sci USA 89:8537-41.
27. Engfeldt P, Arner P. (1988). Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl 19:26-9.
28. Farnier C, Krief S, Blache M, Diot-Dupuy F, Mory G, Ferre P, Bazin R. (2002). The signaling pathway for β1-integrin/ERKs is involved in the adaptation of adipocyte functions to cell size. Ann NY Acad Sci 973:594-7.
29. Faust IM, Johnson PR, Stern JS, Hirsch J. (1978). Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol 4:E279-86.
30. Fernandez-Veledo S, Nieto-Vazquez I, Vila-Bedmar R, Garcia- Guerra L, Alonso-Chamorro M, Lorenzo M. (2009). Molecular mechanisms involved in obesity-associated insulin resistance: Therapeutical approach. Arch Physiol Biochem 115:227-39.
31. Fevrier B, Raposo G. (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16:415-21.
32. Fischer-Posovszky P, Wabitsch M, Hochberg Z. (2007). Endocrinology of adipose tissue - an update. Horm Metabol Res 39:314-21.
33. Freyssinet J-M. (2003). Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655-62.
34. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-8.
35. Guo KY, Halo P, Leibel RL, Zhang Y. (2004). Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 287:R112-99.
36. Häger A., Sjörström L, Arvidsson B, Björntorp P, Smith U. (1978). Adipose tissue cellularity in obese school girls before and after dietary intervention. Am J Clin Nut 31: 68-75.
37. Hamilton BS, Paglia D, Kwan AY, Deitel M. (1995). Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1:953-6.
38. Han CY, Kargi AY, Omer M, Chan CK, Wabitsch M, OBrien KD, Wight TN, Chait A. (2010). Differential effect of saturated and unsaturated free FA on the generation of monocyte adhesion and chemotactic factors by adipocytes. Diabetes 59:386-96.
39. Hauner H. (2005). Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64:163-9.
40. Hauner H. (2010). Adipose tissue inflammation: are small or large fat cells to blame? Diabetologia 53:223-5.
41. Heilbronn L, Smith SR, Ravussin E. (2004). Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes 28:512-21.
42. Hicks GE, Simonsick EM, Harris TB, Newman AB, Weiner DK, Nevitt MA, Tylavsky FA. (2005). Trunk muscle composition as a predictor of reduced functional capacity in the health, aging and body composition study: the moderating role of back pain. J Gerontol 60:1420-4.
43. Hirsch J, Batchelor B. (1976). Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5:299-311.
44. Holm G, Jacobsson B, Bjorntop P, Smith U. (1975). Effects of age and cell size on rat adipose tissue metabolism. J Lipid Res 16:461-4.
45. Hotamisligil GS. (2006). Inflammation and metabolic disorders. Nature 444:860-867.
46. Igarashi M, Jimbu Y, Kimura M, Hirata A, Yamaguchi H, Tominaga M. (2007). Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: A comparison of responders and non-responders. Diabetes Res Clin Pract 77:389-98.
47. Jamdar SC. (1978). Glycerolipid biosynthesis in rat adipose tissue. Influence of adipose cell size and site of adipose tissue on triacylglycerol formation in lean and obese rats. Biochem J 170:153-60.
48. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez- Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. (2005). Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752-60.
49. Johnstone RM. (2006). Exosomes biological significance: a concise review. Blood Cells Mol Dis 36:315-21.
50. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM. (2000). Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501-E8.
51. Julien P, Despres J-P, Angel A. (1989). Scanning electron microscopy of very small fat cells in human obesity. J Lipid Res 30:293-9.
52. Kashiwagi A, Mott D, Bogardus C, Lillioja S, Reaven GM, Foley JE. (1985). The effects of short-term overfeeding on adipocyte metabolism in Pima Indians. Metabolism 34:364-70.
53. Kehayias JJ, Fiatarone MA, Zhuang H, Roubenoff R. (1997). Total body potassium and body fat: relevance to aging. Am J Clin Nutr 66:904-10.
54. Kershaw EE, Flier JS. (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-56.
55. Kiess W, Petzold S, Töpfer M, Garten A, Blüher S, Kapellen T, Körner A, Kratzsch J. (2008). Adipocytes and adipose tissue. Best Pract Clin Endocrinol Metab 22:135-53.
56. Kim K-B, Kim B-W, Choo H-J, Kwon Y-C, Ahn B-Y, Choi J-S, Lee J-S, Ko Y-G. (2009). Proteome analysis of adipocyte lipid rafts reveals that gC1qR plays essential roles in adipogenesis and insulin signal transduction. Proteomics 9:2373-82.
57. Kirkland JL, Dax EM. (1984). Adipose hormone responsiveness and aging in the rat. J Amer Geriatr Soc 32:219-28.
58. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I. (2002). Adipogenesis and aging: does aging make fat go MAD? Exper Gerontol 37:757-7.
59. Klimcakova E, Kovacikova M, Stich V, Langin D. (2010). Adipokines and dietary interventions in human obesity. Obes Rev 11:446-56.
60. Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M et al. (2005). Purification, characterization and biological signficance of tumor-derived exosomes. Anticancer Res 25:3703-7.
61. Körner A, Kratzsch J, Kiess W. (2005). Adipocytokines: leptin - the classical, resistin - the controversial, adiponectin - the promising and more to come. Best Pract Res Clin Endocrinol Metabol 112:525-46.
62. Kral J. (1977). Body composition and adipose tissue cellularity before and after jejuno-ileostomy in severely obese subjects. Eur J Clin Invest 7:413-9.
63. Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. (1999). Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38:202-6.
64. Langin D. (2006). Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53:482-91.
65. Langin D. (2010). Recruitment of brown fat and conversion of white into brown adipocytes: Strategies to fight the metabolic complications of obesity. Biochim Biophys Acta 1801:372-6.
66. Le Lay S, Blouin CM, Hajduch E, Dugail I. (2009). Filling up adipocytes with lipids. Lessons from caveolin-1 deficiency. Biochim Biophys Acta 1791:514-8.
67. Le Lay S, Dugail I. (2009). Connecting lipid droplet biology and the metabolic syndrome. Progr Lipid Res 48:191-5.
68. Li J, Yu X, Pan W, Unger RH. (2002). Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 282:E1334-41.
69. Lonnqvist F, Nordfors L, Jannson M, Thorne A, Schalling M, Arner P. (1997). Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest 99:2398-404.
70. Mack M, Kleinschmidt A, Brühl H, Klier C, Nelson PJ, Cihak J, Plachý J, Stangassinger M, Erfle V, Schlöndorff D. (2000). Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6:769-75.
71. Martin S, Parton RG. (2006). Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7:373-8.
72. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, Chan L. (2000). Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26:474-9.
73. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven GM. (1999). Differences in insulin resistance do not predict weight loss in response to hypocaloric diet in healthy obese women. J Clin Endocrinol Metab 84:578-81.
74. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. (2004). Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53:495-9.
75. McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A. (2010). Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 53:369-77.
76. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW. (2007). Enhanced proportion of small adipose cells in insulin-resistant vs. insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50:1707-15.
77. Medes G, Thomas A, Weinhouse S. (1953). Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13:27-9.
78. Menendez JA, Lupu R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763-77.
79. Miller M. (1984). Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques. J Lipid Res 25:336-47.
80. Mostyn A, Pearce S, Stephenson, Symonds ME. (2004). Hormonal and nutritional regulation of adipose tissue mitochondrial development and function in the newborn. Exp Clin Endocrinol Diabetes 112:2-9.
81. Moller DE. (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-7.
82. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes. Biochemistry 47:1274-87. (Pubitemid 351198704)
83. Müller G, Wied S, Jung C, Over S. (2008b). Translocation of glycosylphosphatidylinositol- anchored proteins to lipid droplets and inhibition of lipolysis in rat adipocytes is mediated by reactive oxygen species. Br J Pharmacol 154:901-13.
84. 2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes. Eur J Pharmacol 597:6-18.
85. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Biochemistry 47:1259-73.
86. 2 and the sulfonylurea drug, glimepiride. Mol Pharmacol 73:1513-29. (Pubitemid 351574841)
87. Müller G, Jung C, Straub J, Wied S. (2009a). Induced release of membrane vesicles and exosomes from rat adipocytes containing lipid droplet, lipid raft and glycosylphosphatidylinositolanchored proteins. Cellular Signalling 21:324-38.
88. Müller G, Jung C, Wied S, Biemer-Daub G. (2009b). Induced translocation of glycosylphosphatidylinositol-anchored proteins from lipid droplets to adiposomes in rat adipocytes. Br J Pharmacol 158:749-70.
89. Müller G, Wied S, Jung C, Biemer-Daub G, Frick W. (2010a). Transfer of Glycosylphosphatidylinositol-anchored 5'-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis. Br J Pharmacol 160:878-91.
90. Müller G, Wied S, Jung C, Frick W, Biemer-Daub G. (2010b). Inhibition of lipolysis by adiposomes containing glycosylphosphatidylinositol- anchored Gce1 protein in rat adipocytes. Arch Physiol Biochem 116:28-41.
91. Müller G, Schulz A, Dearey E-A, Wetekam E-M, Wied S, Frick W. (2010c). Synthetic phosphoinositolglycans regulate lipid metabolism between rat adipocytes via release of GPI-protein-harbouring adiposomes. Arch Physiol Biochem 116:97-115.
92. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W, Cravatt BF. (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140:49-61.
93. Nosjean O, Briolay A, Roux B. (1997). Mammalian GPI proteins: sorting, membrane residence and functions. Biochim Biophys Acta 1331:153-86.
94. Olefsky JM. (1977). Insensitivity of large rat adipocytes to the antilipolytic effects of insulin. J Lipid Res 18:459-64.
95. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri F, Yahagi N, Kraemer FB, Tsutsumi O et al. (2000).Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 97:787-92.
96. Pahor M, Kritchevsky S. (1998). Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 2:97-100.
97. Pfeiffer AFH. (2007). Adipose tissue and diabetes therapy: Do we hit the target? Horm Metab Res 39:734-8.
98. Pilch PF, Bergenheim N. (2006). Pharmacological targeting of adipocytes/ fat metabolism for treatment of obesity and diabetes. Mol Pharmacol 70:779-85.
99. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. (2005). Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 27:375-87.
100. Ploegh H. (2007). A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature 448:435-8.
101. Rabesandratana H, Toutant JP, Reggio H, Vidal M. (1998). Decayaccelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes. Blood 91:1586-9.
102. Ravaglia G, Forti P, Maioli F, Boschi F, Cicognani A, Gasbarrini G. (1999). Measurement of body fat in healthy elderly men: a comparison of methods. J Gerontol 54:M70-6.
103. Rebuffe-Scrive M, Andersson B, Olbe L, Björntop P. (1989). Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 38:453-8.
104. Rodriguez A, Muller DC, Engelhardt M, Andres R. (2005). Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore longitudinal study of aging. Metabolism 54:542-7.
105. Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J et al. (2004). Congenic mice with low serum IGF-1 have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35:1046-58.
106. Razani B, Woodman SE, Lisanti MP. (2002). Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431-67.
107. Salans LB, Knittle JL, Hirsch J. (1968). Role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 47:152-65.
108. Sanderson MP, Keller S, Alonso A, Riedle S, Dempsey PJ, Altevogt P. (2008). Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease- dependent ectodomain shedding and exosome secretion. J Cell Biochem 103:1783-97.
109. Savage DM, Petersen KF, Shulman GI. (2005). Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45:828-33.
110. Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, Ofrecio JM, Chapman J, Subramaniam S. (2009). Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci USA 106:18745-50.
111. Shi Y, Burn P. (2004). Lipid metabolizing enzymes: Emerging drug targets for the treatment of obesity. Nature Rev Drug Discovery 3:695-710.
112. Sims EA, Goldman RF, Gluck CM, Horton ES, Kelleher PC, Rowe DW. (1968). Experimental obesity in man. Trans Assoc Am Physicians 81:153-70.
113. Skog J, Würdinger T, van Rijin S, Meijer DH, Gainche L, Sena- Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biol 10:1470-6.
114. Skurk T, Alberti-Huber C, Herder C, Hauner H. (2007). Relationships between adipocyte size and adipokine expression and secretion. J Clin Endocinol Metabol 92:1023-33.
115. Slawik M, Vidal-Puig AJ. (2006). Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 5:144-64.
116. Smith J, Al-Amri M, Dorairaj P, Sniderman A. (2006). The adipocyte life cycle hypothesis. Clin Sci 110:1-9.
117. Sniderman AD, Cianflone K, Arner P, Summers L, Frayn K. (1998). The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler Thromb Vasc Biol 18:147-51.
118. Snyder PB, Esselstyn JM, Loughney K, Wolda SL, Florio VA. (2005). The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J Lipid Res 46:494-503.
119. Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, Juge-Aubry CE, Dayer JM, Nicklin MJ, Meda P et al. (2006). Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 49:387-93.
120. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T et al. (2008). Dynamics of fat cell turnover in humans. Nature 453:783-7.
121. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P. (1993). Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 268:6823-6.
122. Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J. (1972). Adipose cell size and immunoreactive insulin levels in obese and normal weight adults. Lancet 2:948-51.
123. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. (1992). Metabolic effects of new oral hypoglycaemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203.
124. Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T, Cartwright A, Cartwright M, Flanagan J, Karagiannides I et al. (2007). Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol 292:E298-E307.
125. Trams EG, Lauter CJ, Salem Jr N, Heine U. (1981). Exfoliation of membrane ectoenzymes in the form of microvesicles. Biochim Biophys Acta 645:63-70.
126. Trayhurn P, Wood IS. (2004). Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-55.
127. Trayhurn P, Wang B, Wood IS. (2008). Hypoxia in adipose tissue: a basis for the dysregulation of white adipose tissue. Br J Nutr 100:227-35.
128. Unger RH. (2005). Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. Biochimie 87:57-64.
129. Unger RH. (2003). The physiology of cellular liporegulation. Annu Rev Physiol 65:333-47.
130. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-9.
131. van den Bosch H. (1974). Phosphoglyceride metabolism. Annu Rev Biochem 43:243-77.
132. van Niel G, Porto-Carreiro I, Simoes S, Raposo G. (2006). Exosomes: a common pathway for platelet-derived microparticles. J Biochem 140:3-21.
133. Wang ZW, Pan WT, Lee Y, Kakuma T, Zhou YT, Unger RH. (2001). The role of leptin resistance in the lipid abnormalities of aging. FASEB J 15:108-14.
134. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1785-808.
135. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-5.
136. Yeaman SJ. (2003). Hormone-sensitive lipase - new roles for an old enzyme. Biochem J 379:11-22.
137. Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R. (2005). Lipolysis: pathway under construction. Curr Opin Lipidol 16:333-40.
138. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-32.
139. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R. (2004). Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-6.
140. Zinder O, Shapiro B. (1971). Effect of cell size on epinephrineand ACTH-induced fatty acid release from isolated fat cells. J Lipid Res 12:91-5.
141. Zmuda-Trzebiatowska E, Oknianska A, Manganiello V, Degerman E. (2006). Role of PDE3B in insulin-induced glucose uptake, GLUT4 translocation and lipogenesis in primary rat adipocytes. Cell Signalling 18:382-90.